×
戻る Agenda
S03 : Open Science accelerated by COVID-19, followed by Evidence Generation in the Era of Artificial Intelligence and Digital Transformation
Session Chair(s)
Tadashi Urashima, PhD
Performance and Digital Analytics Lead, Japan Development
GlaxoSmithKline K.K., Japan
Speaker(s)
Behind the Scenes of COVID-19 Clinical Practice Dealing with Emerging Infectious Diseases without Information
Toshibumi Taniguchi, MD, PhD
Chiba University Hospital, Japan
Ayano Hata
Shionogi & Co., Ltd, Japan
Shinsuke Muto
Integrity Healthcare Co., Ltd., Japan
Executive Chairman